Page last updated: 2024-09-05

sorafenib and antrocin

sorafenib has been researched along with antrocin in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(antrocin)
Trials
(antrocin)
Recent Studies (post-2010) (antrocin)
6,5207305,251707

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, MY; Chu, YC; Hsieh, MS; Hsu, CH; Ma, HP; Ong, JR; Setiawan, SA; Tzeng, DTW; Tzeng, YM; Wu, ATH; Yeh, CT1

Other Studies

1 other study(ies) available for sorafenib and antrocin

ArticleYear
Ovatodiolide and antrocin synergistically inhibit the stemness and metastatic potential of hepatocellular carcinoma via impairing ribosome biogenesis and modulating ERK/Akt-mTOR signaling axis.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 108

    Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Diterpenes; Humans; Lactones; Liver Neoplasms; Mice; Neoplastic Stem Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Ribosomes; Sesquiterpenes; Sorafenib; TOR Serine-Threonine Kinases

2023